Back to Search Start Over

An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.

Authors :
Ortiz A
Gui J
Zahedi F
Yu P
Cho C
Bhattacharya S
Carbone CJ
Yu Q
Katlinski KV
Katlinskaya YV
Handa S
Haas V
Volk SW
Brice AK
Wals K
Matheson NJ
Antrobus R
Ludwig S
Whiteside TL
Sander C
Tarhini AA
Kirkwood JM
Lehner PJ
Guo W
Rui H
Minn AJ
Koumenis C
Diehl JA
Fuchs SY
Source :
Cancer cell [Cancer Cell] 2019 Jan 14; Vol. 35 (1), pp. 33-45.e6.
Publication Year :
2019

Abstract

Tumor-derived extracellular vesicles (TEV) "educate" healthy cells to promote metastases. We found that melanoma TEV downregulated type I interferon (IFN) receptor and expression of IFN-inducible cholesterol 25-hydroxylase (CH25H). CH25H produces 25-hydroxycholesterol, which inhibited TEV uptake. Low CH25H levels in leukocytes from melanoma patients correlated with poor prognosis. Mice incapable of downregulating the IFN receptor and Ch25h were resistant to TEV uptake, TEV-induced pre-metastatic niche, and melanoma lung metastases; however, ablation of Ch25h reversed these phenotypes. An anti-hypertensive drug, reserpine, suppressed TEV uptake and disrupted TEV-induced formation of the pre-metastatic niche and melanoma lung metastases. These results suggest the importance of CH25H in defense against education of normal cells by TEV and argue for the use of reserpine in adjuvant melanoma therapy.<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-3686
Volume :
35
Issue :
1
Database :
MEDLINE
Journal :
Cancer cell
Publication Type :
Academic Journal
Accession number :
30645975
Full Text :
https://doi.org/10.1016/j.ccell.2018.12.001